These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12445729)

  • 41. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies.
    Raju KR; Sivasankar B; Anand V; Luthra K; Tiwari SC; Dinda AK; Das N; Srivastava LM
    Asian Pac J Allergy Immunol; 2001 Mar; 19(1):23-7. PubMed ID: 11495296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
    Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
    Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
    J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.
    Ripoche J; Sim RB
    Biochem J; 1986 May; 235(3):815-21. PubMed ID: 2944510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes.
    Chevalier J; Kazatchkine MD
    J Immunol; 1989 Mar; 142(6):2031-6. PubMed ID: 2522131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes.
    Tausk FA; McCutchan JA; Schreiber RD; Spechko P; Gigli I
    Biosci Rep; 1986 Jan; 6(1):81-6. PubMed ID: 2938642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
    Ruuska PE; Ikäheimo I; Silvennoinen-Kassinen S; Käär ML; Tiilikainen A
    Clin Exp Immunol; 1992 Jul; 89(1):18-21. PubMed ID: 1352745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
    Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease in detectable complement receptor type 1 levels on erythrocytes from patients with psoriatic polyarthritis.
    Rivas D; Riestra-Noriega JL; Torre-Alonso JC; Rodriguez A; Gutiérrez C
    Br J Rheumatol; 1994 Jul; 33(7):626-30. PubMed ID: 8019790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.
    Satoh H; Yokota E; Tokiyama K; Kawaguchi T; Niho Y
    Ann Rheum Dis; 1991 Nov; 50(11):765-8. PubMed ID: 1685310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus.
    Tebib JG; Martinez C; Granados J; Alarcon-Segovia D; Schur PH
    Arthritis Rheum; 1989 Nov; 32(11):1465-9. PubMed ID: 2573360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.